Intellia Therapeutics pauses Nex-z gene-editing trial after participant death. Click here for my updated look at NTLA stock ...

In biotech, success often begins in the lab — and for CRISPR pioneers, every clinical trial feels like a moonshot. Gene-editing is not just science but rewriting life itself. For clinical-stage ...

Background Hypertension is a significant risk factor for cardiovascular disease, dementia and chronic kidney disease (CKD).

Market participants were left bewildered on Monday as shares of InnoCan Pharma experienced a severe sell-off, contradicting the positive clinical data the co ...

I often eat mango, jackfruit and durian after dinner, and my recent blood tests showed elevated liver enzymes. Can eating a lot of sweet fruit cause abnormal liver enzymes? (Minh Thu, Ho Chi Minh City ...

HERZLIYA, Israel and CALGARY, Alberta, Nov. 24, 2025 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"), a pioneer in the pharmaceutical ...

On Oct. 8, Metaplanet announced plans to hold an Extraordinary General Meeting (EGM) on Dec. 22, with Oct. 24 as the record date for shareholder eligibility. The board described the fourth quarter as ...

KOLLAM: The state government will organise a seminar to chart a roadmap for Kerala’s animal husbandry sector for the year 2031. The event will feature paper presentations on key areas such as dairy ...

JPMorgan's stock has been fighting to stay above the 50-day moving average, as another close below it could be significant since it would mark the second time in three sessions. The stock fell as much ...

Source Capital's NAV gained 4.59% for the quarter and 13.76% for the trailing twelve months, which is higher than the ...

A new study suggests that the cholesterol-regulating protein PCSK9 may serve as a sensitive early biomarker for autoimmune ...

The way the world grows protein is straining the planet. Raising animals for food covers close to 40 percent of all farmland, ...